Technolas Perfect Vision
Financials
Estimates*
EUR | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
---|---|---|---|---|---|---|---|
Revenues | 45.5m | 49.5m | 52.3m | 55.5m | 29.4m | 31.1m | 36.5m |
% growth | 2 % | 9 % | 6 % | 6 % | (47 %) | 6 % | 17 % |
EBITDA | - | - | - | - | - | <1m | - |
% EBITDA margin | - | - | - | - | - | 1 % | - |
Profit | (35.6m) | (21.6m) | (30.7m) | (13.7m) | (24.9m) | (10.5m) | (2.8m) |
% profit margin | (78 %) | (44 %) | (59 %) | (25 %) | (85 %) | (34 %) | (8 %) |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Acquisition | ||
Total Funding | - |
Recent News about Technolas Perfect Vision
EditTechnolas Perfect Vision GmbH, founded in 1985 in Munich, specializes in high-end laser systems and diagnostic devices for ophthalmic surgery. The company serves eye care professionals and clinics, focusing on refractive, cataract, and therapeutic eye surgeries. Technolas operates in the medical device market, leveraging German engineering to deliver products that combine performance, efficiency, and ease of use. The business model revolves around the sale of advanced laser platforms and diagnostic tools, generating revenue through direct sales and long-term service agreements. In 1998, Technolas was acquired by Bausch & Lomb, and in 2009, it formed a joint venture with 20/10 Perfect Vision to expand its portfolio to include femtosecond lasers. The company aims to improve the quality of life for patients worldwide through innovative technologies.
Keywords: ophthalmic surgery, refractive surgery, cataract surgery, therapeutic eye surgery, laser systems, diagnostic devices, German engineering, medical devices, eye care, Technolas.